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Summary We have examined the expression of major histocompatibility complex (MHC) antigens,
constitutive or induced with interferon gamma (IFN-y), in a line of C3H mouse embryo fibroblasts (C3H2.01)
transformed with a helper-virus-free preparation of the Kirsten strain of murine sarcoma virus. C3H201 cells
expressed some class I antigen (H-2Kk) in the absence of added interferon, unlike the parental C3H lOT1/2
cells from which they were derived. However, this declined with (in vitro) passage level after transformation.
Treatment with IFN-y induced very high expression of H-2Kk at all passage levels. There was no constitutive
expression of class II antigen (I-Ak); however, this could be induced by IFN-y. Inducibility of I-Ak was found
also to be related to the number of passages after transformation; at early passage levels after transformation
more I-Ak was induced than after the cells had been allowed to grow for several passages, until at high
passage levels little or no I-Ak was induced. This was not due to the presence of a subpopulation of
untransformed cells since when the cells were cloned shortly after infection all the resulting clones were
transformed. In addition, IFN-y at any passage level induced clearly less I-Ak than was found in C3H lOT1/2
cells, in which I-Ak inducibility was high and stable. Twenty-one clones were derived from C3H 201 cells at
early passage (<8) either from soft agar or from liquid culture. These clones showed a wide variation in
MHC antigen phenotype. Many expressed H-2Kk in the absence of IFN-y, and all were strongly inducible for
H-2Kk. None showed I-Ak in the absence of IFN-y. All but two expressed I-Ak after IFN-y treatment but,
with four exceptions, clearly less than the untransformed line. Four clones derived at late passage (40)
resembled the late passage line. The expression of the ras oncogene and tumorigenicity was studied in
representative clones; there was no obvious correlation with MHC phenotype, nor with the method of
cloning. We conclude from these studies that the expression of MHC antigens by fibroblasts expressing the v-
Ki-ras oncogene, either with or without exposure to interferon gamma, is unstable, varying with the number
of cell generations from transformation and from clone to clone.
There is accumulating evidence that (at least in experimental
systems) the ability of a tumour to grow in a syngeneic host
is governed by the density of major histocompatibility
complex (MHC) antigens on the surface of the tumour cell
(Goodenow et al., 1985). This is reflected in the finding, for
example, that transfecting MHC antigen genes into an MHC
antigen negative tumour line (so that it becomes antigen
positive) drastically reduces its tumorigenicity (Hui et al.,
1984; Tanaka et al., 1985; Wallich et al., 1985). The
implication of this is that the T cell branch of the immune
system is in somne way important in the control of tumour
growth, although it is of course possible that some other
feature of MHC antigen biology may be involved.
In many cell types the expression of MHC antigens is
inducible, with the interferons (IFNs) being the principle
factors responsible for this induction, although other
cytokines may act as cofactors, either augmenting (e.g.
tumour necrosis factor together with IFN-gamma (IFN-y) in
the induction of class II MHC: Lapierre et al. (1988)) or
reducing (e.g. transforming growth factor together with IFN-
y in the induction of class II: Czarniecki et al. (1988)) MHC
antigen induction. It follows that in any study of the
relationship between MHC antigen phenotype and tumori-
genicity of cells both constitutive and induced MHC antigen
expression should be taken into account. We have previously
noted that in a line of C3H mouse embryo fibroblasts (C3H
lOT1/2) the expression of the v-Ki-ras oncogene influences
the way in which MHC antigens are expressed (Maudsley &
Morris, 1988). The fibroblasts were infected with a helper-
virus-free preparation of the Kirsten strain of murine
sarcoma virus (MSV) to generate a line of cells (C3H 201)
which is malignantly transformed, forming tumours at the
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site of inoculation in syngeneic C3H mice. These
transformed cells when treated with IFN-y express much
reduced levels of MHC class II antigens compared with the
parental, untransformed fibroblasts which after IFN-y
treatment express high levels of these antigens.
Here we report a further investigation of this
phenomenon. The use of helper-virus-free MSV has allowed
us to introduce the v-Ki-ras oncogene with high efficiency
into cells so that we are able to study events very soon after
the transformation of the bulk culture. Alternative
techniques would not permit this; transfection with viral
DNA is very inefficient, and infection with standard virus
preparations would introduce complexities due to the
inevitable presence of the helper leukaemia virus. We have
found that the expression of MHC antigens by the
transformed cells varies with the passage level after
transformation. In a series of clones prepared from the
infected line, which were all clearly transformed at least by
morphological criteria, there was wide variation in the
constitutive and induced expression of MHC antigens. The
implication is that MHC antigen expression in these ras
transformed cells is unstable; this may contribute to the
evolution of such tumours, with selection occurring for
variants which express low levels of MHC antigen, either
constitutive or induced.
Materials and methods
Cells and tissue culture techniques
C3H 1OTl/2 cells (Reznikoff et al., 1973) and their MSV-
transformed derivative C3H 201 (Maudsley & Morris, 1988)
were maintained in the Glasgow modification of Eagle's
minimal essential medium supplemented with 10% fetal calf
serum, subculturing as soon as confluent at a 1:8 ratio (i.e.
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approximately three cell generations per subculture). Cloning
of C3H 201 cells was done either from liquid medium or
from soft agar. In the former case, cells were distributed into
microtitre trays at 1 or 0.3 cells per well in 200p1 of
medium. After 1 week, the tray was scanned and wells
containing single colonies were selected. The medium was
changed weekly in these wells and colonies subcultured by
trypsinisation when large enough. Cloning efficiency under
these conditions was close to 100% for both C3H 10T1/2
and C3H 201 so the technique is not selective for cells with
the transformed phenotype. For soft agar cloning, 5ml
aliquots of culture medium containing 20% fetal calf serum
and 0.4% agar were placed in 5cm Petri dishes and left to
harden. Subsequently duplicate lml aliquots of medium
(20% serum, 0.3% agar) containing either 100 or 1,000 cells
were added. After 10-14 days, large, well-separated colonies
were picked with Pasteur pipettes and placed in liquid
culture. This technique selects cells with the transformed
phenotype and C3H 10T1/2 cells will not grow; the cloning
efficiency of C3H 201 cells under these conditions varies
with passage level (see Results).
To estimate cloning efficiency in soft agar, the numbers of
cells in 20 low power microscope fields of each dish were
counted immediately after plating; 10 days later the numbers
of large colonies in the same number of fields were counted
so that the number of colonies formed per cell plated could
be directly calculated. This method can only give an
approximate measure of cloning efficiency because, especially
at the early passages of C3H 201, many small and
intermediate-sized colonies were formed, which made the
counting uncertain.
For IFN treatment of cells, cultures were treated with a
preparation of recombinant (r-)IFN-y from transfected CHO
cells (Morris & Ward, 1988) at a final concentration of
100luml-1.
Estimation of ras mRNA and p21 protein
The amounts of ras mRNA in cells was determined by dot
blot hybridisation (Siggens, 1988), probing filters dotted with
aliquots of RNA prepared from cells with a 32p labelled
fragment of a cDNA clone (Norton et al., 1984) of the same
MSV used for transformation, quantitating the extent of
hybridisation by liquid scintillation counting of cut-out
pieces of the filter. The p21 protein product was estimated
by Western blotting. Proteins from cells lysed with 2% NP40
were separated electrophoretically, loading equal weights of
protein on to 10% acrylamide gels. After transfer to nitro-
cellulose filters, ras p21 was visualised using a specific
monoclonal antibody (National Cancer Institute, Bethesda,
MD, USA) followed successively by biotinylated sheep anti-
mouse Ig serum and streptavidin-biotinylated horseradish
peroxidase (both from Amersham International plc, UK).
The colour reagent used as substrate for the enzyme was 4-
chloro-l-naphthol (Biorad Laboratories).
Tumorigenicity of cells
Aliquots of 106 cells were inoculated subcutaneously into the
hind legs of 6-8-week-old C3H-He mice from the breeding
colony maintained at this department. The mice were
inspected and palpated over a 6-week period. Tumours
usually appeared at the site of injection within 7-10 days.
Measurement of MHC antigen on cells
Cells were stained as previously described (Maudsley &
Morris, 1988) by indirect fluorescence techniques using
saturating concentrations of monoclonal antibodies. Primary
antibodies used were monoclonal anti-I-Ak, clone 10.3.6,
American Type Culture Collection (ATCC) TIB92; anti-H-
2Kk clone 11.4.1, ATCC TIB95 and a polyclonal FITC
conjugated goat anti-mouse Ig (Capel Laboratories,
Malvern, PA, USA) as second layer. The intensity of
staining was measured using a Becton-Dickinson FACStar
flow cytometer. In our previous experiments (Maudsley &
Morris, 1988; Morris et al., 1989) we found that in C3H
10T1/2 and a number of related transformed lines derived
from it Dk, Kk and I-Ak, I-Ek antigens were co-ordinately
expressed and in this present study Kk and I-Ak antigens are
taken as representative of class I and class II expression.
Results
Expression of MHC antigens by C3H 201 cells as a
function of cell passage
C3H 201 cells were stained at various passages after trans-
formation with the helper-free MSV for H-2Kk and I-Ak
antigens without and with IFN-y in parallel with C3H 10TI/
2. Representative data for C3H 201 obtained four passages
after infection are shown in Figure 1. Usually H-2Kk was
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Figure 1 Expression of MHC antigens by early passage (4p)
C3H 201 cells. Histograms of cell number against log
fluorescence intensity (FLI) stained as described in Materials and
methods. In each panel the close dots indicate the fluorescence of
unstained cells (FITC conjugate alone). a, Cells stained with
anti-I-Ak after IFN-y treatment: solid line, C3H1OT10TI/2 cells;
dashed line, C3H 201 cells. b, Cells stained with anti-H-2Kk
without IFN treatment: solid line, C3H lOT1/2 cells; dashed line,
C3H 201 cells. c, Cells stained with anti-H-2Kk after IFN-y
treatment: solid line, C3H 1OT1/2 cells; dashed line, C3H 201
cells.
:r,
:://
11./MHC ANTIGENS ON ras-TRANSFORMED FIBROBLASTS 213
undetectable on C3H 10T1/2 cells, although occasionally
very low levels were present. On the other hand, when C3H
201 cells were tested soon after transformation, significant
amounts of H-2Kk were present, but the amounts detected
appeared to decline until at passage levels about 20 and
above none was detectable. Both cell types expressed high
levels of H-2Kk after IFN-y treatment. In the absence of
IFN-y no I-A" was present on either cell type. After IFN-y
treatment, C3H 10T1/2 cells reproducibly expressed high
levels of I-Ak irrespective of passage level. At early passages
after transformation, C3H 201 cells also expressed I-Al when
treated with IFN-y, but always less than C3H 10T1/2.
Again, the amount of (induced) I-Ak declined with passage,
so that by about passage 20 little I-Ak could be detected.
However, even at later passages, I-Ak was usually detectable
at low levels on a minority of cells and occasionally at
relatively high levels, although less than at early passages
and always less than C3H 10T1/2 cells.
Cloning of C3H 201 cells and expression of MHC antigens
by clones
Evidently a potential explanation for class II inducible cells
in the C3H 201 line is that uninfected C3H 10T1/2 cells
persist; it is impossible to exclude this completely, but it is
unlikely that many such cells were present since the
multiplicity of infection used was about 3. In addition, when
C3H 201 cells were plated at low frequency on monolayers
of C3H 10T1/2, transformed foci were formed at high
efficiency. Nevertheless, we cloned the line in order to
determine whether indeed there were present untransformed
cells. At passage 2 and again at passage 6 after trans-
formation C3H 201 cells were cloned in liquid medium and
11 clones were so isolated. In order deliberately to select
clones with a transformed phenotype, C3H 201 cells were
cloned at passages 2, 7 and 40 from soft agar, 13 clones
being so isolated. It was found that the plating efficiency of
the cells in soft agar was much lower at early than at late
passage; not only were there proportionally fewer clones but
the growth rate of the colonies was less. All the clones
isolated, either from liquid medium or from soft agar, were
morphologically transformed.
When the MHC expression (without or with IFN-y) of
these clones was examined, wide variations from clone to
clone were found. Some clones were repeatedly tested over
several passages (up to 15) and the MHC phenotype
appeared stable. Several clones expressed H-2Kk in the
absence of IFN; all were induced by IFN-y to express high
levels of H-2KI. None of the clones expressed I-Ak in the
absence of IFN-y. Most of the clones were inducible for I-Ak
to varying degrees. Generally, induced levels of I-Ak were
much lower than for C3H 10T1/2 cells, especially the four
clones obtained at late passage; however, there were four
clones which expressed as much (or more) I-Ak as did C3H
10T1/2 cells. There was no obvious correlation between
method of cloning and MHC phenotype; rather, the corre-
lation was with passage level at cloning. The MHC pheno-
types of all the clones are summarised in Table I and four
contrasting clones (V, D, G and K) are shown in Figure 2.
Expression of ras by selected clones
Although all the clones isolated were morphologically
transformed, we confirmed the expression of ras in
representative clones by detecting mRNA and the p21
protein product. RNA was prepared from seven clones
(367V, 368D and K, 396A, E, F and G) and probed for the
presence of ras mRNA, which was detected in all cases at
above background levels found for C3H 10T1/2 cells. Data
for the four clones in Figure 2 are shown in Table III
together with equivalent data for C3H 10T1/2 and C3H 201.
Western blots showed p21 was present in all seven clones
tested with representative data in Figure 3. Hence the
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Figure 2 MHC phenotype of four clones. Histograms of cell
number against log fluorescence intensity (FLI) stained as
described in Materials and methods. In each panel, solid line is
cells untreated with IFN-y, stained with anti-I-Ak (equivalent to
negative); close dots are cells treated with IFN-y, stained with
anti-I-Ak; spaced dots are cells untreated with IFN-y, stained
with anti-H-2Kk; dashed line is cells treated with IFN-y, stained
with anti-H-2Kk. a, 367V; b, 368D; c, 368K; d, 396G.
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Table I MHC phenotypes of clones
MHC phenotype
Cloning Cloning
Clone passage method
Without IFN-y With IFN-y
H-2Kk I-Ak H-2Kk I-Ak
367A
367B
367C
367D
367V
367W
367X
367Y
367Z
368B
368D
368E
368F
368G
368I
368K
368L
396A
396B
396C
396E
396F
396G
396H
396J
2
2
2
2
6
6
6
6
6
40
40
40
40
7
7
7
7
2
2
2
2
2
2
2
2
agar
agar
agar
agar
liquid
liquid
liquid
liquid
liquid
agar
agar
agar
agar
agar
agar
agar
agar
liquid
liquid
liquid
liquid
liquid
liquid
liquid
liquid
+
+/-
+/-
+/-
+/-
+/-
+/-
+/-
+/
+
+/-
+/-
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
- ++
_ ++
+/-
+
+/-
+l-
+
+-
++-
++-
++-
++-
+/-
+
+ -+
-+
+/
- indicates no staining; +/-, weak staining with most cells
unstained; +, most or all cells stained but less strongly than for
IFN-y treated C3H 10T1/2 cells; + +, staining as strong or stronger
than IFN-y treated C3H 10T1/2 cells.
Table II Expression of ras mRNA by clones
c.p.m. specific hybridisation of ras
specific probe toa
Clone 5pgRNA 10lgRNA 20ugRNA
367V 41 102 194
368D 204 315 766
368K 76 124 456
396G 127 322 590
C3H 201 188 451 928
C3H 10T1/2 0 0 92
aRNA purified from cells was dotted on to filters in the
amounts shown and 32p labelled probe hybridised to the
filters as described, measuring the degree of hybridisation
by scintillation counting.
Table III Anchorage dependence of clones
Approximate % cells
Clone forming colonies in soft agar
367V 84
368D 98
368K 68
396G 21
C3H 201 77
variation in the MHC phenotype of C3H 201 cells with
passage level and among the clones is not likely to be due to
the persistence of a sub-population of untransformed cells.
There was no obvious dependence of MHC expression on
ras expression levels, which appeared similar to C3H 201 in
all the clones tested.
Anchorage dependence and tumorigenicity of selected clones
Again, to confirm the transformed phenotype of the clones,
the anchorage dependence and tumorigenicity of
representative clones was studied. Table III shows the
plating efficiency in agar of clones 367V, 368D and K and
201-00
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Figure 3 Western blots for ras p21 a, clone 367V, b, 396G, c,
C3HIOT1/2; d, C3H 210, e, 368D. Arrows indicate position of
molecular weight markers.
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Figure 3 Western blots for rals p21. a, clone 367V; b, 396G; c,
C3H10T1/2; d, C3H 210; e, 368D. Arrows indicate position of
molecular weight markers.
Table IV Tumorigenicity of clones
Tumours/mice
Clone inoculated (%)
367V 4/16 (25)
368D 8/16 (50)
368K 6/6 (100)
396A 7/10 (70)
396E 7/10 (70)
396F 0/10 (0).
396G 1/18 (6)b
396J 10/10 (100)
C3H 201 10/10 (100)
Mice inoculated with 1 million cells
subcutaneously. The numbers of
tumours indicated were as scored 21
days after inoculation.
aTwo small tumours were noted 7
days after inoculation but both
regressed; b42 days after inoculation
there were 6 small tumours present.
396G together with C3H 201. C3H 10TI/2 cells under these
conditions form no colonies in agar. As can be seen, the
cloning efficiency of the clones is about the same as C3H
201. Similarly, most clones form tumours in mice when
inoculated at 106 cells per mouse (Table IV), tumours
appearing at about the same frequency as when C3H 201
cells were inoculated and growing at about the same rate.
C3H 10T1/2 cells do not form tumours even when larger
numbers of cells (up to 107) are inoculated. Two clones
clearly differed in this respect: 396F and G were much less
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Discussion
The data presented here, together with our earlier
observations, quite clearly shows that the expression of the
v-Ki-ras oncogene influences the expression of MHC
antigens in C3H mouse embryo fibroblasts. Our first
experiments, carried out with C3H 201 cells at relatively
advanced passage levels, showed that there was no
constitutive expression of MHC antigen (as also is the case
with C3H 10T1/2 cells) and that class I but not class II
antigens were inducible, unlike in C3H 10T1/2 cells where
both classes are inducible. The present, more detailed,
examination of the phenomenon has shown the situation to
be more complex. In particular, MHC antigen expression
appears to vary with the number of cell generations after
transformation. When tested very soon after transformation,
the cells very clearly were inducible for class II and some
were constitutively expressing class I antigen. The expression
of class I antigen is not due to the production of IFN by the
cells: none was detectable by bioassay (data not shown). In
addition, class I expressing cells (C3H 201 and 396G) were
co-cultured with a line of Balb/c fibroblasts which are
inducible for class I expression but do not constitutively
express class I antigens; if the C3H cells were producing
IFN, this would induce class I antigens in the Balb/c cells
(H-2d) but this did not occur (data not shown).
An explanation for the presence of class II inducible cells
was that there was a persisting sub-population of cells which
had not been infected with the MSV. The persistence of a
population of untransformed cells is implied by the lower
plating efficiency in soft agar of the early-passage line.
However, an alternative explanation is that (as we have
previously shown (Morris, 1981)), the transformed
phenotype does not fully develop in C3H 10T1/2 cells until
some time after infection with MSV. Hence we prepared
clones from the line at an early passage level in the
expectation that some would be untransformed. None were,
at least by morphology, and although we cannot exclude
that we unconsciously selected clones with transformed
morphology, it became clear in the subsequent analysis of
the clones' properties that high ras expressing clones were
inducible for class II antigens. Hence the mere expression of
ras does not in itself abrogate class II induction.
Our data imply that variations in the inducibility of class
II antigens do not greatly affect the development of tumours,
since there is apparently no correlation of class II
inducibility with tumorigenicity; for example 396A, which is
strongly inducible, appears about as tumorigenic as 368D,
which is not inducible. Two clones which were very much
less tumorigenic than the others were notable in that they
expressed high levels of H-2Kk in the absence of IFN. It may
be that the constitutive expression of class I antigen is a
major determinant of tumorigenicity in this system; in which
case, to study a potential role for induced class II antigens
we should choose class I-negative clones and determine
whether there is then a correlation of class II inducibility
with lower tumorigenicity. An alternative strategy that we
are currently pursuing is to sort (by fluorescence activated
cell sorter) sublines which differ in their inducibility for class
II but otherwise have similar MHC phenotypes (Morris et
al., 1989); these in preliminary experiments do appear to
differ in their tumorigenicity, with the more inducible subline
being less tumorigenic.
Of course, there must be many factors which influence the
ability of cells expressing activated ras to grow as a tumour,
and it is at present impossible to determine whether
instability of MHC antigen expression, either constitutive or
induced, is of decisive importance. However, it is a factor
which needs to be taken into account when considering how
tumours may 'escape' from mechanisms of host control of
tumour growth.
We are very grateful to the Cancer Research Campaign of Great
Britain for generous financial support for this work.
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